Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4785899
Max Phase: Preclinical
Molecular Formula: C135H237N43O36S
Molecular Weight: 3070.71
Molecule Type: Unknown
Associated Items:
ID: ALA4785899
Max Phase: Preclinical
Molecular Formula: C135H237N43O36S
Molecular Weight: 3070.71
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(C)=O)C(C)C)[C@@H](C)CC)C(C)C)C(=O)NC[C@H](C)C(=O)NC[C@H](C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O
Standard InChI: InChI=1S/C135H237N43O36S/c1-19-72(11)105(128(210)153-59-74(13)109(191)152-60-75(14)110(192)171-95(64-179)112(194)154-63-101(187)159-91(47-55-215-18)121(203)173-98(67-182)127(209)178-107(77(16)183)132(214)170-94(58-79-61-151-81-35-22-21-34-80(79)81)124(206)174-97(66-181)126(208)164-85(38-25-29-50-138)117(199)163-88(42-33-54-150-135(146)147)118(200)162-84(37-24-28-49-137)116(198)160-82(108(141)190)36-23-27-48-136)176-122(204)89(43-45-99(140)185)161-111(193)76(15)156-114(196)87(41-32-53-149-134(144)145)166-129(211)104(71(9)10)175-125(207)93(57-69(5)6)169-120(202)90(44-46-102(188)189)165-115(197)83(40-31-52-148-133(142)143)158-100(186)62-155-113(195)96(65-180)172-123(205)92(56-68(3)4)168-119(201)86(39-26-30-51-139)167-131(213)106(73(12)20-2)177-130(212)103(70(7)8)157-78(17)184/h21-22,34-35,61,68-77,82-98,103-107,151,179-183H,19-20,23-33,36-60,62-67,136-139H2,1-18H3,(H2,140,185)(H2,141,190)(H,152,191)(H,153,210)(H,154,194)(H,155,195)(H,156,196)(H,157,184)(H,158,186)(H,159,187)(H,160,198)(H,161,193)(H,162,200)(H,163,199)(H,164,208)(H,165,197)(H,166,211)(H,167,213)(H,168,201)(H,169,202)(H,170,214)(H,171,192)(H,172,205)(H,173,203)(H,174,206)(H,175,207)(H,176,204)(H,177,212)(H,178,209)(H,188,189)(H4,142,143,148)(H4,144,145,149)(H4,146,147,150)/t72-,73-,74-,75-,76-,77+,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,103-,104-,105-,106-,107-/m0/s1
Standard InChI Key: GRGVVCWSRFWQPT-LFEHRRMXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 3070.71 | Molecular Weight (Monoisotopic): 3068.7757 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Mallart S,Ingenito R,Bianchi E,Bresciani A,Esposito S,Gallo M,Magotti P,Monteagudo E,Orsatti L,Roversi D,Santoprete A,Tucci F,Veneziano M,Bartsch R,Boehm C,Brasseur D,Bruneau P,Corbier A,Froissant J,Gauzy-Lazo L,Gervat V,Marguet F,Menguy I,Minoletti C,Nicolas MF,Pasquier O,Poirier B,Raux A,Riva L,Janiak P,Strobel H,Duclos O,Illiano S. (2021) Identification of Potent and Long-Acting Single-Chain Peptide Mimetics of Human Relaxin-2 for Cardiovascular Diseases., 64 (4.0): [PMID:33555858] [10.1021/acs.jmedchem.0c01533] |
Source(1):